| |
| |
|
| Insider
Information: |
Biller Scott |
| Relationship: |
Chief Scientific Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
33,729 |
|
|
Indirect Shares
|
53,059 |
|
|
| Direct
Value |
$1,106,311 |
|
|
|
Indirect Value
|
$1,740,335 |
|
|
| Total
Shares |
86,788 |
|
|
| Total
Value |
$2,846,646 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agios Pharmaceuticals Inc |
AGIO |
Chief Scientific Officer |
2019-06-11 |
33,729 |
2019-06-11 |
53,059 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-06-11 |
4 |
OE |
$2.34 |
$16,872 |
D/D |
7,218 |
33,729 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-04-05 |
4 |
AS |
$67.61 |
$203,135 |
D/D |
(3,000) |
26,511 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-04-05 |
4 |
OE |
$39.76 |
$119,280 |
D/D |
3,000 |
29,511 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-03-05 |
4 |
AS |
$66.45 |
$203,032 |
D/D |
(3,000) |
26,511 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-03-05 |
4 |
OE |
$31.64 |
$115,805 |
D/D |
3,000 |
29,511 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-02-27 |
4 |
AS |
$65.00 |
$585,000 |
D/D |
(9,000) |
26,511 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-02-27 |
4 |
OE |
$0.47 |
$135,875 |
D/D |
9,000 |
35,511 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-02-19 |
4 |
D |
$58.03 |
$50,834 |
D/D |
(876) |
26,511 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,750 |
27,387 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-12-21 |
4 |
OE |
$2.34 |
$47,919 |
D/D |
20,500 |
24,637 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-11-05 |
4 |
OE |
$9.05 |
$27,150 |
D/D |
3,000 |
53,932 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-11-05 |
4 |
AS |
$69.44 |
$209,071 |
D/D |
(3,000) |
50,932 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-10-05 |
4 |
AS |
$68.56 |
$209,377 |
D/D |
(3,000) |
50,932 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-10-05 |
4 |
OE |
$9.05 |
$27,150 |
D/D |
3,000 |
53,932 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-09-05 |
4 |
AS |
$82.52 |
$249,215 |
D/D |
(3,000) |
57,196 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-09-05 |
4 |
OE |
$9.05 |
$27,150 |
D/D |
3,000 |
60,196 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-08-06 |
4 |
AS |
$78.32 |
$240,333 |
D/D |
(3,000) |
57,196 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-08-06 |
4 |
OE |
$9.05 |
$27,150 |
D/D |
3,000 |
60,196 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-07-05 |
4 |
AS |
$83.41 |
$250,503 |
D/D |
(3,000) |
57,196 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-07-05 |
4 |
OE |
$9.05 |
$27,150 |
D/D |
3,000 |
60,196 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-06-05 |
4 |
AS |
$92.45 |
$280,101 |
D/D |
(3,000) |
57,196 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-06-05 |
4 |
OE |
$9.05 |
$27,150 |
D/D |
3,000 |
60,196 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-05-23 |
4 |
OE |
$31.64 |
$480,200 |
D/D |
15,177 |
72,373 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-05-23 |
4 |
AS |
$90.00 |
$1,365,930 |
D/D |
(15,177) |
57,196 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-05-07 |
4 |
AS |
$81.81 |
$245,430 |
D/D |
(3,000) |
57,196 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
